Amicus Therapeutics (NASDAQ:FOLD) Stock, Unusual Options

Amicus Therapeutics

Overview

News

Earnings

Options

Guidance

Analyst Ratings

Insider Trades

Short Interest

Government Trades

Stock Report

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Comments

Amicus Therapeutics Unusual Options